TRCT
PIII icon

Tower Research Capital (TRC)’s P3 Health Partners PIII Stock Holding History

Tower Research Capital (TRC)’s Portfolio PIII Stock Details PIII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.83K Buy
+540
New +$4.02K ﹤0.01% 4254
2024
Q4 		– Sell
-254
Closed -$4.91K – 5927
2024
Q3 		$4.91K Sell
254
-236
-48% -$6.18K ﹤0.01% 4376
2024
Q2 		$11K Buy
490
+285
+139% +$8.51K ﹤0.01% 4106
2024
Q1 		$10.6K Buy
205
+45
+28% +$2.5K ﹤0.01% 3685
2023
Q4 		$11.3K Sell
160
-705
-82% -$48.6K ﹤0.01% 4145
2023
Q3 		$63.6K Buy
865
+682
+373% +$70.8K ﹤0.01% 2346
2023
Q2 		$27.4K Sell
183
-40
-18% -$5.53K ﹤0.01% 3110
2023
Q1 		$12K Buy
223
+136
+156% +$8.17K ﹤0.01% 4113
2022
Q4 		$8K Buy
87
+40
+85% +$8.66K ﹤0.01% 4439
2022
Q3 		$11K Sell
47
-9
-16% -$2.25K ﹤0.01% 4456
2022
Q2 		$10K Buy
56
+54
+2,700% +$15K ﹤0.01% 4473
2022
Q1 		$1K Sell
2
-116
-98% -$34.8K ﹤0.01% 5837
2021
Q4 		$42K Buy
118
+83
+237% +$39.6K ﹤0.01% 2903
2021
Q3 		$17K Buy
35
+33
+1,650% +$16.3K ﹤0.01% 3875
2021
Q2 		$1K Buy
+2
New +$981 ﹤0.01% 5238

Other funds holding PIII

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TFA
Trinity Financial Advisors Columbus, Ohio $389M AUM 20.97% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $72.2B AUM 27.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $1.54B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Tower Research Capital (TRC)'s PIII Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in P3 Health Partners (PIII) in Q2 2026: 540 shares worth $5.83K. The stake represents ﹤0.01% of the portfolio and ranks #4254 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in PIII as recently as Q3 2024.

Tower Research Capital (TRC) first reported a position in PIII in Q2 2021 and has held it in 15 quarters since. The position peaked at $63.6K in Q3 2023. 21 funds tracked by Wall St. Rank hold PIII as of Q2 2026.

  • Tower Research Capital (TRC) held 540 shares of P3 Health Partners worth $5.83K as of Q2 2026.
  • P3 Health Partners was a new Tower Research Capital (TRC) position in Q2 2026.
  • P3 Health Partners made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4254 holding.
  • Tower Research Capital (TRC) first reported a position in P3 Health Partners in Q2 2021 and has held it in 15 quarters since.
  • Tower Research Capital (TRC)'s P3 Health Partners position peaked at $63.6K in Q3 2023.
  • 21 funds tracked by Wall St. Rank held P3 Health Partners as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.